This kind of collaborative is needed, Friend contends, because biologists are starting to see how vast networks of genes get perturbed in complex diseases like cancer, diabetes, and multiple sclerosis. All of this data is too complex for any individual, or team of scientists—even at a place as wealthy as Merck—to fully grasp.
http://www.xconomy.com/seattle/2009/10/06/sage-bionetworks-biologys-open-source-spark-snags-major-donation-from-quintiles/
No comments:
Post a Comment